Mesoglycan Sodium

(BANM, rINNM)

💊 Chemical information

Mesoglicano sódico.

💊 Profile

Mesoglycan sodium is a mucopolysaccharide complex (glycosaminoglycan) extracted from calf aorta, containing mainly suleparoid (heparan sulfate) and dermatan sulfate. It has been claimed to have antithrombotic, antiplatelet, and antihyperlipidaemic properties.
1. Forconi S, et al. A randomized, ASA-controlled trial of mesoglycan in secondary prevention after cerebral ischemic events. Cerebrovasc Dis 1995; 5: 334–41.
2. Laurora G, et al. Controllo della progressione dell’arteriosclerosi in soggetti ad alto rischio trattati con mesoglicano: misurazione dell’intima-media. Minerva Cardioangiol 1998; 46: 41–7
3. Arosio E, et al. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. Eur J Vasc Endovasc Surg 2001; 22: 365–72
4. Nenci GG, et al. Treatment of intermittent claudication with mesoglycan—a placebo-controlled, double-blind study. Thromb Haemost 2001; 86: 1181–7.

💊 Preparations

Proprietary Preparations

Ital.: Perclar†; Prisma; Port.: Prisma.
Published May 08, 2019.